Home › Research › Risk factors
NEIGHBORHOOD DISADVANTAGE AND THE ASSOCIATION OF PLASMA BIOMARKERS WITH COGNITION IN A COHORT OF DIVERSE ADULTS
Erica Fan, Sarah K. Royse, Alexandria C. Reese, Thomas K. Karikari, Tharick Ali Pascoal, C. Elizabeth Shaaban, Victor L. Villemagne, Ann D. Cohen. Innovation in Aging, 2024-12-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Abstract Studies of Alzheimer’s disease pathology have reported associations of plasma Aβ, tau, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) with cognition. However, it remains unclear how these biomarkers are associated with cognition in non-White populations affected by structural racism. Discriminatory policies have long shaped US neighborhood resources. Thus, our aim was to investigate whether neighborhood disadvantage modifies associations of plasma biomarkers with cognition in a diverse cohort of 136 adults ≥50 years. Predictors were plasma biomarkers (Aβ40, Aβ42, pTau217, pTau231, NfL, GFAP) measured using single molecule array or mass spectrometry. Outcomes included cognitive impairment and neuropsychological test scores. Our modifier, neighborhood disadvantage, was measured using area deprivation index (ADI), a composite of socioeconomic condition measures by census tract: higher ADI corresponds with worse conditions. In adjusted linear models, higher ADI, pTau217, pTau231, NfL, and GFAP, and lower Aβ40 and Aβ42 were separately associated with worse cognition. We found ADI*pTau217 interactions on immediate and delayed word recall. In those with low ADI, higher pTau217 was associated with worse immediate (β=-1.82, p=0.005) and delayed recall (β=-22.82, p<0.001); there were no such associations among high ADI participants. We also found an ADI*Aβ40 interaction on Rey figure immediate memory recall such that in low ADI participants, higher Aβ40 was associated with better recall scores (β=0.06, p=0.006), but this association was not significant in high ADI participants. Taken together, relationships between plasma biomarkers and cognition differ by neighborhood conditions, motivating further study of how neighborhood-level factors affect diagnosis and prognostication of cognition.
What this study adds
Evidence grade: Moderate
The record lists 136 participants. In this small cohort of 136 adults, higher neighborhood disadvantage and several plasma biomarkers were each linked to worse cognition, and neighborhood disadvantage changed the link between pTau217 and memory. It is an early biomarker study and does not test any treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Fan, E., Royse, S. K., Reese, A. C., Karikari, T. K., Pascoal, T. A., Shaaban, C. E., et al. (2024). NEIGHBORHOOD DISADVANTAGE AND THE ASSOCIATION OF PLASMA BIOMARKERS WITH COGNITION IN A COHORT OF DIVERSE ADULTS. Innovation in Aging. https://doi.org/10.1093/geroni/igae098.1504
Vancouver
Fan E, Royse SK, Reese AC, Karikari TK, Pascoal TA, Shaaban CE, et al. NEIGHBORHOOD DISADVANTAGE AND THE ASSOCIATION OF PLASMA BIOMARKERS WITH COGNITION IN A COHORT OF DIVERSE ADULTS. Innovation in Aging. 2024. doi:10.1093/geroni/igae098.1504.
BibTeX
@article{fan2024-0f42f421,
author = {Fan, Erica and Royse, Sarah K. and Reese, Alexandria C. and Karikari, Thomas K. and Pascoal, Tharick Ali and Shaaban, C. Elizabeth and Villemagne, Victor L. and Cohen, Ann D.},
title = {{NEIGHBORHOOD DISADVANTAGE AND THE ASSOCIATION OF PLASMA BIOMARKERS WITH COGNITION IN A COHORT OF DIVERSE ADULTS}},
journal = {Innovation in Aging},
year = {2024},
doi = {10.1093/geroni/igae098.1504},
url = {https://doi.org/10.1093/geroni/igae098.1504}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- However, it remains unclear how these biomarkers are associated with cognition in non-White populations affected by structural racism.
- In adjusted linear models, higher ADI, pTau217, pTau231, NfL, and GFAP, and lower Aβ40 and Aβ42 were separately associated with worse cognition.
- We found ADI*pTau217 interactions on immediate and delayed word recall.
- In those with low ADI, higher pTau217 was associated with worse immediate (β=-1.82, p=0.005) and delayed recall (β=-22.82, p<0.001); there were no such associations among high ADI participants.
- We also found an ADI*Aβ40 interaction on Rey figure immediate memory recall such that in low ADI participants, higher Aβ40 was associated with better recall scores (β=0.06, p=0.006), but this association was not significant in high ADI participants.
Why it matters
In this small cohort of 136 adults, higher neighborhood disadvantage and several plasma biomarkers were each linked to worse cognition, and neighborhood disadvantage changed the link between pTau217 and memory. It is an early biomarker study and does not test any treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Participants136
- Evidence strengthModerate
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Innovation in Aging) |
| Journal's citation record | 0 / 4 | Innovation in Aging: journal h-index 48 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 136 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 1 / 6 | Cited 0.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Ann D. Cohen: h-index 44 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Pittsburgh: institution h-index 1,470 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Risk factors from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.